Clinical ResearchPulmonary Vascular DiseaseSafety and Efficacy of Inhaled Treprostinil as Add-On Therapy to Bosentan in Pulmonary Arterial Hypertension
Pulmonary Vascular Disease
Under an Elsevier user license
open archive
Abbreviations and Acronyms
ERA
endothelin receptor antagonist
PAH
pulmonary arterial hypertension
PAPmean
mean pulmonary arterial pressure
PCH
pulmonary capillary hemangiomatosis
PVR
pulmonary vascular resistance
6MWD
6-min walk distance
Cited by (0)
This research was partially funded by LungRx, Satellite Beach, Florida. Drs. Channick, Olschewski, and Seeger have received research funding from LungRx and have also received research funding and been consultants and speakers for Actelion Pharmaceuticals. Mr. Staub is an employee of LungRx. Dr. Rubin has been a consultant, speaker, and received research funding from Actelion Pharmaceuticals and has received research funding and been a consultant for LungRx. Robyn Barst, MD, served as guest editor for this manuscript.
Copyright © 2006 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.